• Record: found
  • Abstract: found
  • Article: not found

Central serous chorioretinopathy: update on pathophysiology and treatment.

Survey of Ophthalmology

Visual Field Tests, Tomography, Optical Coherence, Photochemotherapy, Laser Coagulation, diagnostic use, Indocyanine Green, Humans, Fluorescein Angiography, Coloring Agents, therapy, physiopathology, diagnosis, Central Serous Chorioretinopathy

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      Recent technological advances--new pathophysiological insights, new imaging techniques for diagnosis and management, and new treatments--have led to an improved understanding of central serous chorioretinopathy (CSC). The primary role of the choroid has become more widely accepted with widespread use of indocyanine green angiography. Optical coherence tomography (OCT), and particularly enhanced depth imaging OCT, demonstrate a thickened and engorged choroid. Adaptive optics, fundus autofluorescence, multifocal electroretinography, microperimetry, and contrast sensitivity testing reveal that patients with even a mild course suffer previously undetected anatomic and functional loss. Although focal laser and photodynamic therapy are the current standard of care for persistent subretinal fluid in CSC, they are not appropriate in all cases, and the optimal timing of intervention remains unclear. Published by Elsevier Inc.

      Related collections

      Author and article information



      Comment on this article